1
|
Conte G, Scherr D, Lenarczyk R, Gandjbachkh E, Boulé S, Spartalis MD, Behr ER, Wilde A, Potpara T. Diagnosis, family screening, and treatment of inherited arrhythmogenic diseases in Europe: results of the European Heart Rhythm Association Survey. Europace 2021; 22:1904-1910. [PMID: 33367591 DOI: 10.1093/europace/euaa223] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2020] [Accepted: 07/10/2020] [Indexed: 01/12/2023] Open
Abstract
The spectrum of inherited arrhythmogenic diseases (IADs) includes disorders without overt structural abnormalities (i.e. primary inherited arrhythmia syndromes) and structural heart diseases (i.e. arrhythmogenic ventricular cardiomyopathy, hypertrophic cardiomyopathy). The aim of this European Heart Rhythm Association (EHRA) survey was to evaluate current clinical practice and adherence to 2015 European Society of Cardiology Guidelines regarding the management of patients with IADs. A 24-item centre-based online questionnaire was presented to the EHRA Research Network Centres and the European Cardiac Arrhythmia Genetics Focus Group members. There were 46 responses from 20 different countries. The survey revealed that 37% of centres did not have any dedicated unit focusing on patients with IADs. Provocative drug challenges were widely used to rule-out Brugada syndrome (BrS) (91% of centres), while they were used in a minority of centres during the diagnostic assessment of long-QT syndrome (11%), early repolarization syndrome (12%), or catecholaminergic polymorphic ventricular tachycardia (18%). While all centres advised family clinical screening with electrocardiograms for all first-degree family members of patients with IADs, genetic testing was advised in family members of probands with positive genetic testing by 33% of centres. Sudden cardiac death risk stratification was straightforward and in line with current guidelines for hypertrophic cardiomyopathy, while it was controversial for other diseases (i.e. BrS). Finally, indications for ventricular mapping and ablation procedures in BrS were variable and not in agreement with current guidelines in up to 54% of centres.
Collapse
Affiliation(s)
- Giulio Conte
- Division of Cardiology, Cardiocentro Ticino, Lugano, Switzerland.,Faculty of Biomedical Sciences, USI, Lugano, Switzerland.,Centre for Computational Medicine in Cardiology, Faculty of Informatics, Università della Svizzera Italiana, Lugano, Switzerland
| | - Daniel Scherr
- Division of Cardiology, Medical University of Graz, Austria
| | - Radoslaw Lenarczyk
- First Department of Cardiology and Angiology, Silesian Centre for Heart Disease, Zabrze, Poland
| | - Estelle Gandjbachkh
- Department of Cardiology, Sorbonne Universités, APHP, Cardiology Institute, ICAN, Pitié-Salpêtrière University Hospital, Paris, France
| | - Stéphane Boulé
- Department of Cardiology, Hôpital privé Le Bois, Lille, France
| | | | - Elijah R Behr
- Department of Cardiology, Cardiology Clinical Academic Group, St. George's, University of London and St. George's University Hospitals NHS Foundation Trust, London, UK.,ERN GUARDHEART
| | - Arthur Wilde
- ERN GUARDHEART.,Amsterdam UMC, University of Amsterdam, Heart Center; Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands
| | - Tatjana Potpara
- ERN GUARDHEART.,School of Medicine, University of Belgrade, Belgrade, Serbia.,Cardiology Clinic, Clinical Centre of Serbia, Belgrade, Serbia
| |
Collapse
|
2
|
Conte G, Wilde A, Behr ER, Scherr D, Lenarczyk R, Gandjbachkh E, Crotti L, Brugada-Sarquella G, Potpara T. Importance of Dedicated Units for the Management of Patients With Inherited Arrhythmia Syndromes. Circ Genom Precis Med 2021; 14:e003313. [PMID: 33797288 DOI: 10.1161/circgen.120.003313] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Giulio Conte
- Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano, Switzerland (G.C.).,Faculty of Biomedical Sciences, USI, Lugano, Switzerland (G.C.)
| | - Arthur Wilde
- ERN GUARDHEART (A.W., E.R.B., E.G., L.C., G.B.-S.).,Department of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Heart Center, the Netherlands (A.W.)
| | - Elijah R Behr
- ERN GUARDHEART (A.W., E.R.B., E.G., L.C., G.B.-S.).,Cardiology Clinical Academic Group, St. George's, University of London & St. George's University Hospitals NHS Foundation Trust, London, United Kingdom (E.R.B.)
| | - Daniel Scherr
- Division of Cardiology, Medical University of Graz, Austria (D.S.)
| | - Radoslaw Lenarczyk
- First Department of Cardiology & Angiology, Silesian Center for Heart Disease, Zabrze, Poland (R.L.)
| | - Estelle Gandjbachkh
- ERN GUARDHEART (A.W., E.R.B., E.G., L.C., G.B.-S.).,Sorbonne Universités, APHP, Cardiology Inst, ICAN, Pitié-Salpêtrière University Hospital, Paris, France (E.G.)
| | - Lia Crotti
- ERN GUARDHEART (A.W., E.R.B., E.G., L.C., G.B.-S.).,Istituto Auxologico Italiano, IRCCS, Cardiomyopathy Unit, Department of Cardiovascular, Neural & Metabolic Sciences, San Luca Hospital, Milan, Italy (L.C.).,Istituto Auxologico Italiano, IRCCS, Center for Cardiac Arrhythmias of Genetic Origin & Laboratory of Cardiovascular Genetics, Milan, Italy (L.C.)
| | - Georgia Brugada-Sarquella
- ERN GUARDHEART (A.W., E.R.B., E.G., L.C., G.B.-S.).,Cardiovascular Inst, Hospital Clínic Pediatric Arrhythmia Unit, Hospital Sant Joan de Déu University of Barcelona, Spain (G.B.-S.)
| | - Tatjana Potpara
- School of Medicine, University of Belgrade, Belgrade, Serbia. Cardiology Clinic, Clinical Center of Serbia, Belgrade (T.P.)
| |
Collapse
|